Hazard
2,384 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.
Of the 2,384 sterility recalls we have scored against our rubric, 1 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 2,114 (89%) are Severe.
Which agencies issued them
Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all sterility recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.
A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.
Bedford Pharmacy is recalling Methylcobalamin 1 mg/mL Injection because there is a lack of assurance of sterility. The product was distributed in New Hampshire and Massachusetts.
Bedford Pharmacy is recalling 4 vials of P-P-P (COBAL) 30-1-20/mL Injection due to a lack of assurance of sterility. The product was distributed in New Hampshire and Massachusetts.
Bedford Pharmacy is recalling Methylcobalamin (Bacteriostatic) 1 mg/mL Injection due to a lack of assurance of sterility. The product was distributed in New Hampshire and Massachusetts.
Bedford Pharmacy is recalling four vials of P-P (COBAL) 30-2 /mL Injection because of a lack of assurance of sterility. The product was distributed in New Hampshire and Massachusetts.
Bedford Pharmacy is recalling Testosterone Cypionate (Complete Formula) 200 mg/mL injections due to a lack of assurance of sterility. The product was distributed in New Hampshire and Massachusetts.
Bedford Pharmacy is recalling P-P (COBAL) 300-30/mL injections because there is a lack of assurance of sterility. The affected product was distributed in New Hampshire and Massachusetts.
Bedford Pharmacy is recalling P-P (COBAL) 30-0.5/mL injections because there is a lack of assurance of sterility. The product was distributed in New Hampshire and Massachusetts.
Bedford Pharmacy is recalling two bottles of Acetylcysteine 10% Ophthalmic Solution because there is a lack of assurance of sterility.
Bedford Pharmacy is recalling Testosterone Cypionate injections due to a lack of assurance of sterility. The affected products were distributed in New Hampshire and Massachusetts.
Bedford Pharmacy is recalling Hydroxocobalamin 20 mg/mL Injection due to a lack of assurance of sterility. The product was distributed in New Hampshire and Massachusetts.
Bedford Pharmacy is recalling P-P-P (COBAL) 30-1-5/mL Injection vials because the agency could not ensure the product was sterile. The recall affects vials distributed in New Hampshire and Massachusetts.
Bedford Pharmacy is recalling P-P-P (COBAL) 30-2-30/mL injections because of a lack of assurance of sterility. The product was distributed in New Hampshire and Massachusetts.
The Compounding Pharmacy of America is recalling Morphine 10 mg/ml Solution due to FDA inspection findings regarding GMP violations and lack of sterility assurance.
The Compounding Pharmacy of America is recalling Testosterone 70 mg sterile pellets due to FDA inspection findings of GMP violations that may impact sterility.
The Compounding Pharmacy of America is recalling Baclofen 1,000 mcg/ml Intrathecal Solution due to FDA inspection findings of GMP violations that may impact sterility.
The Compounding Pharmacy of America is recalling Tri-Mix injectable products because FDA inspections found GMP violations that may affect sterility.
The Compounding Pharmacy of America is recalling Sufentanil and Bupivacaine Solution due to FDA inspection findings regarding sterility assurance.
The Compounding Pharmacy of America is recalling Hydroxocobalamin and Folic Acid injectable vials due to FDA-identified GMP violations affecting sterility.
The Compounding Pharmacy of America is recalling Betamethasone Sodium Phosphate injectable due to FDA inspection findings of GMP violations that may impact sterility.
The Compounding Pharmacy of America is recalling HCG 5,000 IU/ml injections due to FDA inspection findings of GMP violations that may impact sterility.
The Compounding Pharmacy of America is recalling Alprostadil 20 mcg/ml Injection because an FDA inspection identified GMP violations that may impact sterility.
The Compounding Pharmacy of America is recalling Cyanocobalamin and B-Complex injections due to FDA inspection findings of GMP violations that may impact sterility.
The Compounding Pharmacy of America is recalling a compounded intrathecal solution because an FDA inspection found GMP violations that may affect sterility.
The Compounding Pharmacy of America is recalling Alprostadil 50 mcg/ml Injection because an FDA inspection found GMP violations that may impact sterility.
The Compounding Pharmacy of America is recalling Testosterone Cypionate and Anastrazole injections due to FDA inspection findings of GMP violations that may impact sterility.